全文获取类型
收费全文 | 5664篇 |
免费 | 391篇 |
国内免费 | 407篇 |
出版年
2023年 | 84篇 |
2022年 | 97篇 |
2021年 | 297篇 |
2020年 | 194篇 |
2019年 | 235篇 |
2018年 | 234篇 |
2017年 | 176篇 |
2016年 | 252篇 |
2015年 | 351篇 |
2014年 | 437篇 |
2013年 | 460篇 |
2012年 | 511篇 |
2011年 | 434篇 |
2010年 | 290篇 |
2009年 | 261篇 |
2008年 | 294篇 |
2007年 | 219篇 |
2006年 | 204篇 |
2005年 | 194篇 |
2004年 | 187篇 |
2003年 | 164篇 |
2002年 | 119篇 |
2001年 | 121篇 |
2000年 | 88篇 |
1999年 | 115篇 |
1998年 | 53篇 |
1997年 | 38篇 |
1996年 | 43篇 |
1995年 | 40篇 |
1994年 | 33篇 |
1993年 | 19篇 |
1992年 | 29篇 |
1991年 | 24篇 |
1990年 | 34篇 |
1989年 | 9篇 |
1988年 | 21篇 |
1987年 | 14篇 |
1986年 | 9篇 |
1985年 | 9篇 |
1984年 | 10篇 |
1983年 | 8篇 |
1982年 | 7篇 |
1981年 | 5篇 |
1980年 | 6篇 |
1979年 | 3篇 |
1978年 | 3篇 |
1977年 | 3篇 |
1975年 | 6篇 |
1974年 | 3篇 |
1965年 | 2篇 |
排序方式: 共有6462条查询结果,搜索用时 312 毫秒
71.
72.
73.
74.
M W Wong C B Xia M L Chen C X Zhang P S Mao G Q Nei Y Hosaka 《Japanese journal of medical science & biology》1988,41(1):31-36
Molluscicidal activity of B-2 (sodium 2,5-dichloro-4-bromophenol; called as Phebrol and registered in WHO as OMS 3012) was evaluated in a laboratory and the field trials were performed in two different localities in Yueyang city, China, for control of Oncomelania hupensis. B-2 was effective against O. hupensis both in the laboratory and in the field. A dosage of 50 g/m2 in 10% granular form or 20 ml/m2 in 25% liquid form of B-2 would be recommendable as a standard mollusciciding dose for control of O. hupensis. 相似文献
75.
微生态药物在许多复杂性和慢性疾病中显示出极大的潜力,逐渐成为国际制药行业的新趋势。基于科睿唯安旗下的Cortellis数据库,采用定量分析和专家智慧相结合的方法,从总体研发现状、主要国家/地区、主要适应症、重点企业研发管线、重点在研药物、商业化交易多个维度展现全球微生态药物的研发和商业化全景。分析结果显示:全球共有142个在研微生态药物,其中49个药物处于临床阶段。美国在微生态药物研发和商业化方面遥遥领先,其数量占在研药物总量的70%。在研药物的适应症主要集中于炎症性肠病、艰难梭菌感染、溃疡性结肠炎等肠道感染性疾病。4D pharma公司的在研药物数量最多,微生态药物重点研发企业均建立起核心技术平台。处于临床3期的微生态药物共有7个,全球微生态药物商业化交易共有303起,最大的交易金额是27.8亿美元。未来,微生态药物有望在更难被人类征服的肿瘤和神经系统疾病方面取得突破性进展。 相似文献
76.
miR164c and miR168a regulate seed vigor in rice 总被引:1,自引:0,他引:1
Yan Zhou Shiqi Zhou Liping Wang Duo Wu Hailan Cheng Xu Du Dandan Mao Chunlai Zhang Xiaocheng Jiang 《植物学报(英文版)》2020,62(4):470-486
77.
Yunhong Tian Yunming Tian Yinuo Tu Guoqian Zhang Xing Zeng Jie Lin Meiling Ai Zixu Mao Ronghui Zheng Yawei Yuan 《Journal of cellular and molecular medicine》2020,24(17):9533-9544
Cancer stem cells (CSCs) are a source of tumour recurrence in patients with nasopharyngeal carcinoma (NPC); however, the function of microRNA‐124 (miR‐124) in NPC CSCs has not been clearly defined. In this study, we investigated the role of miR‐124 in NPC CSCs. qRT‐PCR was performed to measure miR‐124 expression in NPC tissues and cell lines and the effects of miR‐124 on stem‐like properties and radiosensitivity of NPC cells measured. Luciferase reporter assays and rescue experiments were used to investigate the interaction of miR‐124 with the 3′UTR of junctional adhesion molecule A (JAMA). Finally, we examined the effects of miR‐124 in an animal model and clinical samples. Down‐regulation of miR‐124 was detected in cancer tissues and was inversely associated with tumour stage and lymph node metastasis. Overexpression of miR‐124 inhibited stemness properties and enhanced radiosensitivity of NPC cells in vitro and in vivo via targeting JAMA. Up‐regulation of miR‐124 was correlated with superior overall survival of patients with NPC. Our study demonstrates that miR‐124 can inhibit stem‐like properties and enhance radiosensitivity by directly targeting JAMA in NPC. These findings provide novel insights into the molecular mechanisms underlying therapy failure in NPC. 相似文献
78.
Zhao Shan Li Zhiyong Xin Xiangdong Zhang Bei Jiang Xizhi Thomas Attaribo Charles Asakiya Zhang Lei Gui Zhongzheng 《International journal of peptide research and therapeutics》2020,26(4):1913-1921
International Journal of Peptide Research and Therapeutics - Silk fibroin is an excellent raw material for medical products as it shows remarkable biocompatibility, water-based processing, and... 相似文献
79.
80.
Zhiyong Fan Yinghui Liu Zhengliang Shi Kai Deng Hua Zhang Qiutong Li Shuxing Cao Shentai Li Hongliang Zhang 《Journal of cellular and molecular medicine》2020,24(15):8441-8451
Osteoarthritis (OA) is a common joint disease characterized by progressive cartilage degradation, in which elevated chondrocyte apoptosis and catabolic activity play an important role. MicroRNA‐155 (miR‐155) has recently been shown to regulate apoptosis and catabolic activity in some pathological circumstances, yet, whether and how miR‐155 is associated with OA pathology remain unexplored. We report here that miR‐155 level is significantly up‐regulated in human OA cartilage biopsies and also in primary chondrocytes stimulated by interleukin‐1β (IL‐1β), a pivotal pro‐catabolic factor promoting cartilage degradation. Moreover, miR‐155 inhibition attenuates and its overexpression promotes IL‐1β‐induced apoptosis and catabolic activity in chondrocytes in vitro. We also demonstrate that the PIK3R1 (p85α regulatory subunit of phosphoinositide 3‐kinase (PI3K)) is a target of miR‐155 in chondrocytes, and more importantly, PIK3R1 restoration abrogates miR‐155 effects on chondrocyte apoptosis and catabolic activity. Mechanistically, PIK3R1 positively regulates the transduction of PI3K/Akt pathway, and a specific Akt inhibitor reverses miR‐155 effects on promoting chondrocyte apoptosis and catabolic activity, phenocopying the results obtained via PIK3R1 knockdown, hence establishing that miR‐155 promotes chondrocyte apoptosis and catabolic activity through targeting PIK3R1‐mediated PI3K/Akt pathway activation. Altogether, our study discovers novel roles and mechanisms of miR‐155 in regulating chondrocyte apoptosis and catabolic activity, providing an implication for therapeutically intervening cartilage degradation and OA progression. 相似文献